Evidence map›Paper›PMID 20308390›Full record

ArticleAntimicrobial agents and chemotherapy2010

In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.

Lucio Vera-Cabrera, Mayra Paola Campos-Rivera, Wendy G Escalante-Fuentes, Michael J Pucci, Jorge Ocampo-Candiani, Oliverio Welsh

Open access · greenAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Mycetoma medical therapy.PLoS neglected tropical diseases · 2014
    Review
  2. Article
  3. Article
  4. Carbapenems: past, present, and future.Antimicrobial agents and chemotherapy · 2011
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lucio Vera-CabreraServicio de Dermatologia, Hospital Universitario, Madero y Gonzalitos, Colonia Mitras Centro, Monterrey, NL, México. luvera_99@yahoo.com
Mayra Paola Campos-Rivera
Wendy G Escalante-Fuentes
Michael J Pucci
Jorge Ocampo-Candiani
Oliverio Welsh
Hospital Universitario Dr José Eleuterio Gonzalez · MXAchillion Pharmaceuticals (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The in vitro activities of ACH-702 and other antimicrobials against 30 Nocardia brasiliensis isolates were tested. The MIC(50) (MIC for 50% of the strains tested) and MIC(90) values of ACH-702 were 0.125 and 0.5 microg/ml. The same values for econazole were 2 and 4 microg/ml. The MIC(50) and MIC(90) values of imipenem and meropenem were 64 and >64 microg/ml and 2 and 8 microg/ml, respectively; the addition of clavulanic acid to the carbapenems had no effect.

Indexed as

Anti-Bacterial AgentsClavulanic AcidDrug Therapy, CombinationEconazoleHumansImipenemIn Vitro TechniquesMeropenemMycetomaNocardiaNocardia InfectionsQuinolonesThiazolesThienamycinsACH 702Anti-Bacterial AgentsClavulanic AcidEconazoleImipenemMeropenemQuinolonesThiazolesThienamycins

Identifiers

PMID20308390
PMCPMC2863655
OpenAlexW1998595333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.